StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
016100.KQ$1203.00-5.65%
Fair $1203.00+0.0%

016100.KQ

Leaders Cosmetics Co., Ltd.

Consumer Defensive / Household & Personal ProductsKOSDAQ

$1203.00

-72.00 (-5.65%)

Fairly Valued+0.0%Fair Value $1203.00Fund rank 23/100 · Data gapFallback financials|
SA 5/F
F-Score: 1/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-6.5B · quality 41.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

5/100

F

Piotroski

1/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -29.1%, below the 5% threshold
Thesis & Journal · 016100.KQLocal privado en este navegador · Leaders Cosmetics Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$22.1B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-29.1%

↓

Gross Margin

15.7%

↓

Debt/Equity

1.03

↑
52-Week Range$1203
$1111$3100

TradingView lightweight chart

016100.KQ price, volumen y niveles de valoración

Último $1,203Periodo +71.9%
Fair value: $1,203

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-7.6%

FCF CAGR

—

FCF margin

-9.5%

FCF / Net income

0.78x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $68.31B · net income $-8.32B · FCF $-6.46B

2022-FY → 2025-FY

Gross margin

15.7%-4.1% pts

Operating margin

-10.4%-11.0% pts

Net margin

-12.2%-11.4% pts

FCF margin

-9.5%-11.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$68.31B$68.31B$73.50B$69.28B$86.66B
Net Income$-8.32B$-8.32B$-3.20B$235.5M$-687.4M
EBITDA$-4.65B$-4.65B$-1.16B$-2.83B$2.37B
EPS-454.00-454.00-174.0013.00-46.00
Gross Margin15.7%15.7%18.7%18.2%19.8%
Operating Margin-10.4%-10.4%-3.9%-6.2%0.6%
Net Margin-12.2%-12.2%-4.4%0.3%-0.8%
Balance Sheet
Debt/Equity1.031.030.720.600.59
Current Ratio0.540.54———
Cash Flow
Free Cash Flow$-6.46B$-6.46B$-4.32B$-7.33B$1.95B
Returns
ROE-29.1%-29.1%-8.6%0.5%-1.6%
Valuation
P/E———179.62—
EV/EBITDA————27.28
P/B0.770.771.240.961.07
Growth & Yield
Revenue Growth-7.1%-7.1%6.1%-20.1%—
EPS Growth-160.9%-160.9%-1438.5%128.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -47.1%

Total return

-47.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-174.00 → -454.00

Residual

-47.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-47.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.